<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Epidemiological studies indicate that the intake of <z:chebi fb="5" ids="47916">flavonoids</z:chebi> is inversely associated with risk of <z:hpo ids='HP_0001297'>stroke</z:hpo>, <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular diseases</z:e> and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Isoliquiritigenin (ISL), a <z:chebi fb="5" ids="47916">flavonoid</z:chebi> constituent in the root of Glycyrrhiza glabra, is known to have vasorelaxant effect, <z:chebi fb="11" ids="22586">antioxidant</z:chebi>, anti-platelet, anti-<z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>, anti-allergic, antiviral activities and estrogenic properties </plain></SENT>
<SENT sid="2" pm="."><plain>However, there is no report on the effects of ISL in <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Evidence demonstrate that the impaired energy metabolism and the excessive generation of reactive oxygen radicals (ROS) contribute to the brain injury associated with <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>In the present study, the protective effects of ISL were investigated in transient middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO)-induced focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>-reperfusion injury in rats </plain></SENT>
<SENT sid="5" pm="."><plain>Male Sprague-Dawley rats were divided into five groups: sham-operated group, vehicle-pretreated group, and three ISL-pretreated groups (5, 10 and 20 mg kg(-1), i.g.) </plain></SENT>
<SENT sid="6" pm="."><plain>ISL were administered once a day, for 7 days prior to <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>The rats were subjected to 2 h right MCAO via the intraluminal filament technique and 22 h reperfusion </plain></SENT>
<SENT sid="8" pm="."><plain>Pretreatment with ISL significantly reduced the cerebral <z:mpath ids='MPATH_124'>infarct</z:mpath> volume and <z:hpo ids='HP_0000969'>edema</z:hpo> and produced significant reduction in neurological deficits </plain></SENT>
<SENT sid="9" pm="."><plain>In this study, in order to clarify the mechanism of ISL's protection against <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> damage, cerebral energy metabolism, brain Na+K+ATPase activity, malondialdehyde (<z:chebi fb="14" ids="32506">MDA</z:chebi>) content and <z:chebi fb="11" ids="22586">antioxidant</z:chebi> enzyme activities were measured </plain></SENT>
<SENT sid="10" pm="."><plain>ISL pretreatment increased the brain ATP content, energy charge (EC) and total <z:chebi fb="1" ids="16708">adenine</z:chebi> <z:chebi fb="9" ids="36976">nucleotides</z:chebi> (TAN) in a dose-dependent manner </plain></SENT>
<SENT sid="11" pm="."><plain>The brain Na+K+ATPase activity was protected significantly by pretreatment of ISL for 7 days </plain></SENT>
<SENT sid="12" pm="."><plain>Pretreatment with ISL significantly inhibited the increases of brain <z:chebi fb="14" ids="32506">MDA</z:chebi> content and prevented the activities of brain <z:chebi fb="1" ids="18421">superoxide</z:chebi> dismutase (SOD), catalase (CAT) and <z:chebi fb="0" ids="16856">glutathione</z:chebi> peroxidase (GSH-Px) from declines caused by <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>-reperfusion </plain></SENT>
<SENT sid="13" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> these findings indicate that ISL has the protective potential against <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> injury and its protective effects may be due to the amelioration of cerebral energy metabolism and its <z:chebi fb="11" ids="22586">antioxidant</z:chebi> property </plain></SENT>
</text></document>